A/Prof Priscilla HOW

A/Prof Priscilla HOW

Associate Professor Priscilla HOW

Pharm.D., BCPS, BSc (Pharm) Hons

Director, Master of Pharmacy (Clinical Pharmacy) Program, NUS
Director, Doctor of Pharmacy Program, NUS
Senior Principal Clinical Pharmacist, NUH
Collaborative Prescribing Pharmacist, NUH

Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore
18 Science Drive 4, Singapore 117543
Tel: +65 6516 4906
Fax: +65 6779 1554
Email: phahowp@nus.edu.sg

Teaching Activities at NUS Pharmacy

  • Nephrology pharmacy (pharmacokinetics, pharmacotherapy, fluid and electrolyte disorders)
  • Applied patient care skills (clinical lab interpretation, history taking, communications skills, physical assessment, research methods and clinical research)
  • Seminar and debates
  • Objective Structured Clinical Examination (OSCE)
Undergraduate
  • PR1150: Professional Identity and Skills Development I
  • PR2150: Professional Identity and Skills Development II
  • PR2155: Hepatic and Renal Systems: Science & Therapeutics
  • PR3150: Professional Identity and Skills Development III
  • PR4150: Professional Identity and Skills Development IV [Coordinator]
Postgraduate
  • PR5113: Clinical Pharmacokinetics & Therapeutic Drug Monitoring
  • PR5131: Advanced Pharmacotherapy I
  • PR5134: Advanced Skills in Pharmacy Practice [Coordinator]
  • PR5134A: Physical Assessment and Diagnostic Tests for Advanced Pharmacy Practice [Coordinator]
  • PR5135: Foundations in Advanced Pharmacy Practice
  • PR5136: Postgraduate Seminar and Teaching [Coordinator]
  • PR5311: Foundational Therapeutics in Clinical Pharmacy [Coordinator]
  • Clinical Clerkship in Nephrology Pharmacotherapy

    • Apr 2026 to Present: Ex-Officio Member, Industry Advisory Board, Department of Pharmacy & Pharmaceutical Sciences, NUS
    • Apr 2026 to Present: Member of Pharmacist Training Pathway Committee – Advanced Practice Workgroup, MOH, Singapore
    • Apr 2025 to Present: Member of Pro-Tem Committee for Pharmacy Specialization in Nephrology, MOH, Singapore
    • Jan 2023 to Present: Member of the Singapore Pharmacy Council Board of Examiners, Singapore Pharmacy Council, Singapore
    • Jul 2022 to Jun 2024: Member of the PharmForce Workstream 2 (Role & Scope of Practice) Committee, MOH, Singapore
    • May 2019 to Present: Co-Chair of Pharmacy Residency Selection Committee, MOH, Singapore
    • Nov 2018 to Present: Member of the Department Teaching Excellence Committee, Department of Pharmacy, NUS
    • Feb 2017 to Jan 2023: Member of National Collaborative Prescribing Standing Committee, MOH, Singapore
    • 2017 to May 2023: Pharmacy Lead of National Collaborative Prescribing Program Curriculum Committee, MOH, Singapore
    • Sep 2020 to Sep 2021: Chair of National R1 Exemption Review Committee, MOH, Singapore
    • 2017 to Present: Member of the Pharmacy Program Review Committee, Singapore Pharmacy Council
    • 2017 to 2018: Chair of National Collaborative Prescribing Program Training and Education SubCommittee, MOH, Singapore
    • 2016-2017 and 2020-2021: Chair for Discretionary Admission Management Committee Department of Pharmacy, NUS
    • 2024: Awarded NUS Faculty Teaching Excellence Award (FTEA) 2024 on Jan 17, 2025
    • 2019: Awarded 10-year long service award by National University of Singapore
    • 2018: Awarded the Minister for Health Award by Ministry of Health, Singapore, in recognition of the contribution and exemplary service in advancing the Ministry of Health’s strategic priorities and initiatives in Collaborative Prescribing. This award is the highest accolade conferred by the Ministry of Health, on individuals or teams
    • 2018: Received the 5-year Long Service Award from Ministry of Health, Singapore, for serving in the Pharmacy Specialists Accreditation Board of Singapore (PSAB)
    • 2009/2010: Voted “Model Pharmacist” under the faculty category for “In the Spotlight”, organized by the Hospital Chapter of the Pharmaceutical Society of Singapore
    • 2007: Awarded the Fellowship Research Award by the University of Illinois at Chicago, College of Pharmacy, Dept of Pharmacy Practice
    • 2006: Received Board certification in Pharmacotherapy (BCPS) from the Board of Pharmaceutical Specialties (BPS), USA
    • 2005: Awarded the Richard A. Hutchinson Award by the University of Illinois at Chicago, College of Pharmacy, Dept of Pharmacy Practice, and University of Illinois Hospital, Dept of Pharmacy Services for excellence in pharmacy practice
    • 2004: Awarded High Honors by the University of Illinois at Chicago, College of Pharmacy, for outstanding academic performance in the Pharm.D. program
    • 2004: Awarded the GlaxoSmithKline Patient Care Award by GlaxoSmithKline, in recognition of outstanding performance during pharmacy rotations in the 2003-2004 academic year
    • 2002: Awarded the I.B. Crystal Memorial Award by the University of Illinois at Chicago, College of Pharmacy, for a perfect Grade Point Average (GPA) score of 5.0 for Fall 2001
    • 2002: Awarded High Honors by the University of Illinois at Chicago, College of Pharmacy, for outstanding academic performance in the second year Pharm.D. program
    • 2001 to 2004: Awarded the Lee Foundation Study Award by the Lee Foundation, Singapore, for overseas postgraduate education (Pharm.D.) in the United States of America
    • 1999: Awarded First Class Honors by the National University of Singapore for exemplary performance in the B.Sc.(Pharmacy) Honors course
    • Management of anemia and iron deficiency in CKD
    • Optimal use of phosphate binders, active vitamin D and calcimimetics in the management of chronic kidney disease (CKD) mineral and bone disorder
    • Effects of vitamin D receptor gene polymorphisms on clinical outcomes in CKD patients
    • Optimal and cost-effective medication use in CKD patients
    • Pharmacotherapeutics in supportive care for end stage kidney disease patients
    • Nephrology Pharmacy Services for CKD and dialysis patients
    • Bachelor of Science in Pharmacy (First Class Honors), National University of Singapore
    • Doctor of Pharmacy (Pharm.D.), University of Illinois at Chicago, Illinois, USA
    • Pharmacy Practice Residency (PGY1), University of Illinois Medical Center at Chicago and University of Illinois at Chicago, Illinois, USA
    • Nephrology Research Fellowship, University of Illinois at Chicago, Illinois, USA
    1. WL Leow, DZW Ng, IWJ Sing, KJX Peck, E Lo, YT Chua, MBH Lee, P How, ECY Chan. Physicochemical stability of vancomycin–cefepime admixtures in peritoneal dialysis solutions. Submitted for publication in Jun 2026.
    2. Teo BW, Messner JS, Chua HR, How P, Demirjian S. Slow continuous therapies. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis, 6th Lippincott Williams and Wilkins, Philadelphia, PA. 2024. Published in Jun 2025.
    3. Lim FTS, Ong SY, How P, Lo E. Evaluating Light-Sensitive Injectables: Gaps in Manufacturers’ Package Inserts and Recommendations for Best Practices. Proceedings in Singapore Healthcare. Accepted for publication in May 2025.
    4. Yong MHA, Seng JJB, Tan YLC, Wong J, How P. Prevalence and outcomes associated with hypocalcemia and hypercalcemia among pre-dialysis chronic kidney disease patients with mineral and bone disorder. Singapore Medical Journal 2024 Aug 1;65(8):421-429. doi: 10.4103/singaporemedj.SMJ-2021-391.
    5. How P, Lau A. Fluid and electrolyte disorders. In: Zeind CS, Carvalho MG, Cheng JWM, Zaiken K, LaPointe T eds. Applied therapeutics: the clinical use of drugs, 12th Wolters Kluwer Health, Philadelphia, PA. 2023; 602-631 (Chapter 27). Published in Jan 2023.
    6. Lim SER, How P, Ngoh LYC, Yong XN, Wong WK, Lo E. Phosphorus content of commonly prescribed medications among patients with chronic kidney disease. Journal of Renal Nutrition 2022 Jan;32(1):22-29. doi: 10.1053/j.jrn.2021.08.010.Epub 2021 Oct 6.
    7. Han Z, Chui WK, Wang A, How P, Chew EH, Tan KB, Chen ZX, Tai CW, The SY, Gallagher P. Design and Implementation of Synchronous Online Team-Based Learning: A Reflection on Students’ Experiences and Lessons Learned. Asian Journal of the Scholarship of Teaching and Learning (Reflections on practice) 2021;11(2):142-151.
    8. Kwan YH, Fong W, How P, Wee HL, Leung YY, Phang JK, Tan CS, Malhotra R, Ostbye T, Thumboo J. The impact of axial spondyloarthritis on quality of life (QoL): A comparison with the impact of moderate to end-stage chronic kidney disease on QoL. 2018. Quality of Life Research. 27:2321-2327.
    9. HL Wee, Seng B, JJ Lee, Tyagi P, Vathsala A, How P. Association of Anemia and Mineral and Bone Disorders on Health-Related Quality of Life in Predialysis Patients. Health Qual Life Outcomes 2016 Jun 24;14(1):94. doi: 10.1186/s12955-016-0477-8.
    10. Lau BC, Ong KY, Yap CW, Vathsala A, How P. Predictors of Anemia in a Multi-Ethnic Chronic Kidney Disease Population: A Case-Control Study. SpringerPlus 2015 May 20;4:233. doi: 10.1186/s40064-015-1001-z. eCollection 2015.
    11. Chuang SH, HC Wong, Vathsala A, E Lee, How P. Prevalence of Chronic Kidney Disease-Mineral and Bone Disorder in Incident Peritoneal Dialysis Patients and its Impact on Short Term Morbidity and Mortality. Singapore Med J 2015; 1-23; http://dx.doi.org/10.11622/smedj.2015195 Epub: 29 Dec 2015; actual publication: 2016;57:603-609.
    12. Ngai M, Lin V, HC Wong, Vathsala A, How P. Vitamin D Status and its Association with Mineral and Bone Disorders in a Multi-Ethnic Chronic Kidney Disease Population in Southeast Asia. Clin Nephrol 2014;82:231-239.
    • Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmaceutical Specialties, USA
    • Collaborative Prescribing Practitioner (Pharmacist), Singapore
    • Registered Pharmacist in Singapore and Illinois, USA